BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Beverly A. Teicher. Immunotherapy for Gastrointestinal Cancer2017; : 79 doi: 10.1007/978-3-319-43063-8_4
2
Wei Zhu, Liang Ye, Jianzhao Zhang, Pengfei Yu, Hongbo Wang, Zuguang Ye, Jingwei Tian, Irina V Lebedeva. PFK15, a Small Molecule Inhibitor of PFKFB3, Induces Cell Cycle Arrest, Apoptosis and Inhibits Invasion in Gastric CancerPLOS ONE 2016; 11(9): e0163768 doi: 10.1371/journal.pone.0163768
3
Ying Fu, Hui Li, Xishan Hao. The self-renewal signaling pathways utilized by gastric cancer stem cellsTumor Biology 2017; 39(4): 101042831769757 doi: 10.1177/1010428317697577
4
Ling Qiu, Hui Yang, Gaochao Lv, Ke Li, Guiqing Liu, Wei Wang, Shanshan Wang, Xueyu Zhao, Minhao Xie, Jianguo Lin. Insights into the mevalonate pathway in the anticancer effect of a platinum complex on human gastric cancer cellsEuropean Journal of Pharmacology 2017; 810: 120 doi: 10.1016/j.ejphar.2017.06.035
5
Xiaofei Ni, Yanpeng Xing, Xuan Sun, Jian Suo. The safety and efficacy of anti-PD-1/anti-PD-L1 antibody therapy in the treatment of previously treated, advanced gastric or gastro-oesophageal junction cancer: A meta-analysis of prospective clinical trialsClinics and Research in Hepatology and Gastroenterology 2019;  doi: 10.1016/j.clinre.2019.05.007
6
Minghui Zhang, Yuandi Dong, Haitao Liu, Yan Wang, Shu Zhao, Qijia Xuan, Yan Wang, Qingyuan Zhang. The clinicopathological and prognostic significance of PD-L1 expression in gastric cancer: a meta-analysis of 10 studies with 1,901 patientsScientific Reports 2016; 6(1) doi: 10.1038/srep37933